萬里揚(002434.SZ):目前公司主要為奇瑞汽車配套乘用車變速器
格隆匯3月22日丨有投資者於投資者互動平台向萬里揚(002434.SZ)提問,“面對公司大客户奇瑞汽車40%以上的增長,公司在配套中如何調整產品結構?輕卡,重卡,商用生產線是否可以通用”,公司回覆稱,目前,公司主要為奇瑞汽車配套乘用車變速器。奇瑞汽車整車銷量的增長,有力推動了公司為其配套產品的產銷量增長。公司輕卡變速器和重卡變速器產品的部分零部件加工產線可以共用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.